FSSNX
Price
$37.34
Change
+$0.10 (+0.27%)
Updated
Sep 4 closing price
Net Assets
34.47B
TSMOX
Price
$19.09
Change
+$0.06 (+0.32%)
Updated
Sep 4 closing price
Net Assets
2.76B
Interact to see
Advertisement

FSSNX vs TSMOX

FSSNX vs TSMOX Comparison Chart in %
View a ticker or compare two or three
VS
FSSNX vs. TSMOX commentary
Sep 08, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSSNX is a Hold and TSMOX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSSNX has more cash in the bank: 34.5B vs. TSMOX (2.76B). FSSNX pays higher dividends than TSMOX: FSSNX (1.05) vs TSMOX (0.59). FSSNX was incepted earlier than TSMOX: FSSNX (15 years) vs TSMOX (10 years). TSMOX (0.69) is less costly to investors than FSSNX (0.03). TSMOX is a more actively managed with annual turnover of: 89.00 vs. FSSNX (80.00). FSSNX (0) and TSMOX (0) have matching initial minimum investment requirements. FSSNX annual gain was more profitable for investors over the last year : 26.74 vs. TSMOX (17.28). FSSNX return over 5 years is better than : 36.27 vs. TSMOX (10.16).
FSSNXTSMOXFSSNX / TSMOX
Total Expense Ratio0.030.694%
Annual Report Gross Expense Ratio0.030.694%
Fund Existence15 years10 years-
Gain YTD20.89422.84491%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets34.5B2.76B1,249%
Annual Yield % from dividends1.050.59178%
Returns for 1 year26.7417.28155%
Returns for 3 years65.3650.01131%
Returns for 5 years36.2710.16357%
Returns for 10 years139.8896.44145%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGSOX17.810.05
+0.28%
Grandeur Peak Global Stalwarts Investor
DOMIX13.25-0.01
-0.08%
Domini Impact International Equity Inv
JHEQX35.78-0.07
-0.20%
JPMorgan Hedged Equity I
NEIAX58.11-0.21
-0.36%
Columbia Large Cap Index A
BRUKX19.52-0.11
-0.56%
MFS Blended Research Value Equity R2